These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 2163202)
1. Insulin-sensitive tyrosine kinase: relationship with in vivo insulin action in humans. Nyomba BL; Ossowski VM; Bogardus C; Mott DM Am J Physiol; 1990 Jun; 258(6 Pt 1):E964-74. PubMed ID: 2163202 [TBL] [Abstract][Full Text] [Related]
2. Role of human skeletal muscle insulin receptor kinase in the in vivo insulin resistance of noninsulin-dependent diabetes mellitus and obesity. Nolan JJ; Freidenberg G; Henry R; Reichart D; Olefsky JM J Clin Endocrinol Metab; 1994 Feb; 78(2):471-7. PubMed ID: 8106637 [TBL] [Abstract][Full Text] [Related]
3. Elevation of serum insulin concentration during euglycemic hyperinsulinemic clamp studies leads to similar activation of insulin receptor kinase in skeletal muscle of subjects with and without NIDDM. Klein HH; Vestergaard H; Kotzke G; Pedersen O Diabetes; 1995 Nov; 44(11):1310-7. PubMed ID: 7589829 [TBL] [Abstract][Full Text] [Related]
4. Decreased tyrosine kinase activity in partially purified insulin receptors from muscle of young, non-obese first degree relatives of patients with type 2 (non-insulin-dependent) diabetes mellitus. Handberg A; Vaag A; Vinten J; Beck-Nielsen H Diabetologia; 1993 Jul; 36(7):668-74. PubMed ID: 8395436 [TBL] [Abstract][Full Text] [Related]
5. Reversibility of defective adipocyte insulin receptor kinase activity in non-insulin-dependent diabetes mellitus. Effect of weight loss. Freidenberg GR; Reichart D; Olefsky JM; Henry RR J Clin Invest; 1988 Oct; 82(4):1398-406. PubMed ID: 3170749 [TBL] [Abstract][Full Text] [Related]
6. Decreased muscle insulin receptor kinase correlates with insulin resistance in normoglycemic Pima Indians. Youngren JF; Goldfine ID; Pratley RE Am J Physiol; 1997 Aug; 273(2 Pt 1):E276-83. PubMed ID: 9277380 [TBL] [Abstract][Full Text] [Related]
7. Effect of metformin treatment on insulin action in diabetic rats: in vivo and in vitro correlations. Rossetti L; DeFronzo RA; Gherzi R; Stein P; Andraghetti G; Falzetti G; Shulman GI; Klein-Robbenhaar E; Cordera R Metabolism; 1990 Apr; 39(4):425-35. PubMed ID: 2157941 [TBL] [Abstract][Full Text] [Related]
8. In vivo stimulation of the insulin receptor kinase in human skeletal muscle. Correlation with insulin-stimulated glucose disposal during euglycemic clamp studies. Freidenberg GR; Suter SL; Henry RR; Reichart D; Olefsky JM J Clin Invest; 1991 Jun; 87(6):2222-9. PubMed ID: 1645756 [TBL] [Abstract][Full Text] [Related]
9. Insulin signalling in skeletal muscle of subjects with or without Type II-diabetes and first degree relatives of patients with the disease. Meyer MM; Levin K; Grimmsmann T; Beck-Nielsen H; Klein HH Diabetologia; 2002 Jun; 45(6):813-22. PubMed ID: 12107725 [TBL] [Abstract][Full Text] [Related]
10. Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects. Bogardus C; Lillioja S; Howard BV; Reaven G; Mott D J Clin Invest; 1984 Oct; 74(4):1238-46. PubMed ID: 6384267 [TBL] [Abstract][Full Text] [Related]
12. Effects of NIDDM on the glucose transport system in human skeletal muscle. Scheck SH; Barnard RJ; Lawani LO; Youngren JF; Martin DA; Singh R Diabetes Res; 1991 Mar; 16(3):111-9. PubMed ID: 1802477 [TBL] [Abstract][Full Text] [Related]
13. Activation of skeletal muscle casein kinase II by insulin is not diminished in subjects with insulin resistance. Maeda R; Raz I; Zurlo F; Sommercorn J J Clin Invest; 1991 Mar; 87(3):1017-22. PubMed ID: 1999482 [TBL] [Abstract][Full Text] [Related]
15. Decreased kinase activity of insulin receptors from adipocytes of non-insulin-dependent diabetic subjects. Freidenberg GR; Henry RR; Klein HH; Reichart DR; Olefsky JM J Clin Invest; 1987 Jan; 79(1):240-50. PubMed ID: 3540010 [TBL] [Abstract][Full Text] [Related]
16. Influence of hyperglycemia on insulin's in vivo effects in type II diabetes. Revers RR; Fink R; Griffin J; Olefsky JM; Kolterman OG J Clin Invest; 1984 Mar; 73(3):664-72. PubMed ID: 6368585 [TBL] [Abstract][Full Text] [Related]
17. In vitro reversal of hyperglycemia normalizes insulin action in fat cells from type 2 diabetes patients: is cellular insulin resistance caused by glucotoxicity in vivo? Burén J; Lindmark S; Renström F; Eriksson JW Metabolism; 2003 Feb; 52(2):239-45. PubMed ID: 12601640 [TBL] [Abstract][Full Text] [Related]
18. Insulin resistance is associated with impaired nitric oxide synthase activity in skeletal muscle of type 2 diabetic subjects. Kashyap SR; Roman LJ; Lamont J; Masters BS; Bajaj M; Suraamornkul S; Belfort R; Berria R; Kellogg DL; Liu Y; DeFronzo RA J Clin Endocrinol Metab; 2005 Feb; 90(2):1100-5. PubMed ID: 15562034 [TBL] [Abstract][Full Text] [Related]
19. Defective insulin receptor tyrosine kinase in human skeletal muscle in obesity and type 2 (non-insulin-dependent) diabetes mellitus. Arner P; Pollare T; Lithell H; Livingston JN Diabetologia; 1987 Jun; 30(6):437-40. PubMed ID: 2824266 [TBL] [Abstract][Full Text] [Related]
20. Insulin resistance in the pathogenesis of NIDDM in Pima Indians. Bogardus C Diabetes Care; 1993 Jan; 16(1):228-31. PubMed ID: 8422780 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]